RESUMEN
Risk for transmission of monkeypox virus (MPXV) (clade IIb) to healthcare workers (HCWs) is low. Although many cases have been reported among HCW, only a few have been occupationally acquired. We report a case of non-needle stick MPXV transmission to an HCW in the United States.
Asunto(s)
Monkeypox virus , Mpox , Humanos , Mpox/diagnóstico , Mpox/epidemiología , California/epidemiología , Personal de SaludRESUMEN
In July 2014, as the Ebola virus disease (Ebola) epidemic expanded in Guinea, Liberia, and Sierra Leone, an air traveler brought Ebola to Nigeria and two American health care workers in West Africa were diagnosed with Ebola and later medically evacuated to a U.S. hospital. New York City (NYC) is a frequent port of entry for travelers from West Africa, a home to communities of West African immigrants who travel back to their home countries, and a home to health care workers who travel to West Africa to treat Ebola patients. Ongoing transmission of Ebolavirus in West Africa could result in an infected person arriving in NYC. The announcement on September 30 of an Ebola case diagnosed in Texas in a person who had recently arrived from an Ebola-affected country further reinforced the need in NYC for local preparedness for Ebola.
Asunto(s)
Epidemias/prevención & control , Fiebre Hemorrágica Ebola/prevención & control , Vigilancia de la Población , Fiebre Hemorrágica Ebola/epidemiología , Humanos , Ciudad de Nueva York/epidemiologíaRESUMEN
The increase in drug-resistant Streptococcus pneumoniae has led to concerns about antibiotic resistance. Otitis media is the leading indication for antibiotic use in the United States. Evidence suggests that antibiotics do provide benefit to children with documented acute otitis media, and that carefully selected children may respond to shorter courses of antibiotics. Despite the increase in resistance, amoxicillin remains the drug of choice for acute otitis media even in areas with high levels of resistance. Pneumococcal conjugate vaccine and live attenuated influenza vaccine, which may be licensed in the future, will both have an impact on acute otitis media. During the next few years, these vaccines, along with more stringent diagnostic criteria, and more judicious use of antibiotics, may all contribute towards reducing the incidence of acute otitis media, the number of antibiotic prescriptions given and the adverse impact of antimicrobial resistance.
